☰

James A. Daniel, PhD - Publications

Affiliations: 
2003-2009 Neurodegeneration Lab Garvan Institute of Medical Research/UNSW Australia 
 2009-2013 Cell Signalling Children's Medical Research Institute, New South Wales, Australia, Westmead, New South Wales, Australia 
 2013- Molecular Neurobiology Max-Planck-Institut für Multidisziplinäre Naturwissenschaften 
Area:
Synaptic transmission, dopamine, endocytosis, drug discovery, imaging
Website:
https://www.mpinat.mpg.de/de/daniel
Tree Info Grants Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Odell LR, Jones NC, Chau N, Robertson MJ, Ambrus JI, Deane FM, Young KA, Whiting A, Xue J, Prichard K, Daniel JA, Gorgani NN, O'Brien TJ, Robinson PJ, McCluskey A. The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models. Rsc Medicinal Chemistry. 14: 1492-1511. PMID 37593570 DOI: 10.1039/d2md00371f  0.54
2023 Daniel JA, Elizarova S, Shaib AH, Chouaib AA, Magnussen HM, Wang J, Brose N, Rhee J, Tirard M. An intellectual-disability-associated mutation of the transcriptional regulator impairs glutamatergic neurotransmission. Frontiers in Molecular Neuroscience. 16: 1115880. PMID 37533751 DOI: 10.3389/fnmol.2023.1115880  0.449
2022 Elizarova S, Chouaib AA, Shaib A, Hill B, Mann F, Brose N, Kruss S, Daniel JA. A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution. Proceedings of the National Academy of Sciences of the United States of America. 119: e2202842119. PMID 35613050 DOI: 10.1073/pnas.2202842119  0.433
2018 Daniel JA, Cooper BH, Palvimo JJ, Zhang FP, Brose N, Tirard M. Response: Commentary: Analysis of SUMO1-conjugation at synapses. Frontiers in Cellular Neuroscience. 12: 117. PMID 29766991 DOI: 10.3389/fncel.2018.00117  0.444
2017 Daniel JA, Cooper BH, Palvimo JJ, Zhang FP, Brose N, Tirard M. Analysis of SUMO1-conjugation at Synapses. Elife. 6. PMID 28598330 DOI: 10.7554/eLife.26338  0.498
2016 Odell LR, Abdel-Hamid MK, Hill TA, Chau N, Young KA, Deane FM, Sakoff JA, Andersson S, Daniel JA, Robinson PJ, McCluskey A. Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain. Journal of Medicinal Chemistry. PMID 27997171 DOI: 10.1021/acs.jmedchem.6b01422  0.547
2015 Daniel JA, Chau N, Abdel-Hamid MK, Hu L, von Kleist L, Whiting A, Krishnan S, Maamary P, Joseph SR, Simpson F, Haucke V, McCluskey A, Robinson PJ. Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. Traffic (Copenhagen, Denmark). 16: 635-54. PMID 25693808 DOI: 10.1111/tra.12272  0.567
2013 McCluskey A, Daniel JA, Hadzic G, Chau N, Clayton EL, Mariana A, Whiting A, Gorgani NN, Lloyd J, Quan A, Moshkanbaryans L, Krishnan S, Perera S, Chircop M, von Kleist L, et al. Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic (Copenhagen, Denmark). 14: 1272-89. PMID 24025110 DOI: 10.1111/Tra.12119  0.539
2013 McGeachie AB, Odell LR, Quan A, Daniel JA, Chau N, Hill TA, Gorgani NN, Keating DJ, Cousin MA, van Dam EM, Mariana A, Whiting A, Perera S, Novelle A, Young KA, et al. Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors. Acs Chemical Biology. 8: 1507-18. PMID 23642287 DOI: 10.1021/Cb400137P  0.585
2012 Daniel JA, Malladi CS, Kettle E, McCluskey A, Robinson PJ. Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening. Nature Protocols. 7: 1439-55. PMID 22767087 DOI: 10.1038/nprot.2012.070  0.541
2010 Galbraith S, Daniel JA, Vissel B. A study of clustered data and approaches to its analysis Journal of Neuroscience. 30: 10601-10608. PMID 20702692 DOI: 10.1523/Jneurosci.0362-10.2010  0.517
2010 Odell LR, Howan D, Gordon CP, Robertson MJ, Chau N, Mariana A, Whiting AE, Abagyan R, Daniel JA, Gorgani NN, Robinson PJ, McCluskey A. The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening. Journal of Medicinal Chemistry. 53: 5267-80. PMID 20575553 DOI: 10.1021/Jm100442U  0.574
2010 Hill TA, Mariana A, Gordon CP, Odell LR, Robertson MJ, McGeachie AB, Chau N, Daniel JA, Gorgani NN, Robinson PJ, McCluskey A. Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis. Journal of Medicinal Chemistry. 53: 4094-102. PMID 20426422 DOI: 10.1021/jm100119c  0.55
2009 Daniel JA, Galbraith S, Iacovitti L, Abdipranoto A, Vissel B. Functional heterogeneity at dopamine release sites Journal of Neuroscience. 29: 14670-14680. PMID 19923300 DOI: 10.1523/Jneurosci.1349-09.2009  0.584
2009 Abdipranoto-Cowley A, Jin SP, Croucher D, Daniel J, Henshall S, Galbraith S, Mervin K, Vissel B. Activin A is essential for neurogenesis following neurodegeneration Stem Cells. 27: 1330-1346. PMID 19489097 DOI: 10.1002/Stem.80  0.562
Show low-probability matches.